Navigation Links
S7 Zipper MX

ProductsS7 Zipper MX
Company Medtronic Inc.
Item S7 Zipper MX
Features Unique Modular Design. Designed for Direct Stenting. Thin struts for efficient scaffolding and optimal metal-to-artery ratio Smallest cell area due to shorter segments and more crowns. High radial strength and low recoil for maximum MLD. Optimal radiopacity facilitates placement and lesion assessment.
Description The S7 gives enhanced deliverability and unmatched scaffolding. The Zipper MX Platform gives your short-wire capability and the option to change wires and catheters. Secure Technology Stent Retention System for added security during delivery. Discrete Technology designed to minimize balloon overhang. Clinical applications include: Saphenous vein grafts; Lesions on a bend; Tapered vessels.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Driver Zipper MX Coronary Stent System
2. Zippered Male Vest
3. Black Spandex Above the Knee Compression Girdles with Hook & Eye with Zipper
4. Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper
5. 8000 Series with Zippers - 1st Stage
6. 9000 Series with Zippers - 1st Stage
7. Abdominoplasty Girdle with Zippers - 1st Stage
8. Abdominoplasty Girdle without Zippers - 2nd Stage
9. Zippered Abdominal Girdle
10. Male Abdominoplasty Girdle with Zippers - 1st Stage
TAG: Zipper
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products:
(Date:12/2/2008)...ers using functional MRI (fMRI) have determined th...ble for suppressing memory is dysfunctional in pat...sorders. Results of the study will be presented to...ety of North America (RSNA). , "For patients wi...ders, traumatic memories are a source of anxiety,"...
(Date:12/2/2008).... 3 Representatives from the fitne...) paid a visit to the Shriners,Hospitals for Chil...traordinary, albeit unique, cause; The Burn Machin...endly exercise equipment to the first ever Shriner... http://www.newscom.com/cgi-bin/prnh/20081203/CLW...
(Date:12/2/2008)...hers from Monash University, The Brigham and Women...anda Pharmaceuticals has found a new drug with the...s caused by shift work. , Dr Shantha Rajaratnam...ychiatry and Psychological Medicine said tasimelte...e brain, could be a highly effective treatment for...
(Date:12/2/2008)... Smile Reminder, the nation,s leadi...nveiled the latest in industry,technology today a...tal tool,for capturing and distributing video tes...ent testimonials onto popular platforms such as Yo...ool provides doctors with an effective,business s...
Breaking Medicine News(10 mins):Health News:Stress-related disorders affect brain’s processing of memory 2Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3
...preclinical trail, that siRNA packed as a tiny sph... the University of Texas M. D. Anderson Cancer Cen...nical Cancer Research, that siRNA that are wrapped... into ovarian cancer tumour cells, which could the...
...Autism could affect the entire brain, not just the...r, and reasoning it had been once thought.// A ne... in Autism (CPEA) has shown that autism affects a ... perception, movement and memory. The researchers ...
...d that Thailand’s Public Health Ministry will enco...y to help screen patients in an attempt// to preve...h Minister Pinij Charusombat said, the blue-collar...ies instead of visiting doctors, may be left out f...
...nternational AIDS Conference in Toronto have warne... plunging into a silent epidemic of AIDS//. Only 0...rth Africa carry the virus that causes AIDS. The ...of HIV infection in the world according to UNAIDS ...
Other Medicine News:Health News:Tiny Sphere Of Nanoparticles Can Fight Cancer 2Health News:Tiny Sphere Of Nanoparticles Can Fight Cancer 3Health News:Effects Of Autism On Brain Much Wider Than Presumed 2Health News:Risk of Silent AIDS epidemic in Middle East and North Africa 2
(Date:12/1/2008)...ewswire-FirstCall/ -- Genaera Corporation (Nasdaq... has begun in study MSI-1436C-102 (Study 102), the...uemine (MSI-1436) in overweight and obese type 2 d...treatment of type 2 diabetes and obesity which wor...and leptin pathways through the highly selective i...
(Date:12/1/2008)...tCall/ -- Vical Incorporated (Nasdaq: VICL ) ann...ne payment from Merck & Co., Inc. based on Mer...l of an investigational plasmid DNA (pDNA) cancer ... DNA gene delivery technology and encodes human te...he subject of separate license agreement. , ,...
(Date:11/28/2008)...FirstCall/ -- Eli Lilly and Company,(NYSE: LLY ...ion (sNDA) from,the U.S. Food and Drug Administra...he management of chronic pain. Lilly plans to resu...dding data from a recently completed positive stud... The decision does not affect duloxetine,s FD...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-First...SF) announced today that it has received full appr...DA) for its U.S. pivotal trial to study the effect...d associated therapy in the prevention of Contrast...o approved PLC,s request to expand their investiga...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Vigorous activity protects against breast cancer 28359 1Vigorous activity protects against breast cancer 28359 2The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 1The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 2The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 3The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 4The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 5The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 6The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 7The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 8The Ensign Group Inc Reports Third Quarter 2008 Earnings 3B Reaffirms 2008 Guidance 28357 9Heavy Metals Can Taint Wine 28355 1Heavy Metals Can Taint Wine 28355 2Heavy Metals Can Taint Wine 28355 3Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 1Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 2
...ORK--(BUSINESS WIRE)--Jul 6, 2007 - ZIOPHARM Oncol...Jonathan Lewis, Chief,Executive Officer, will pres...Opportunities Conference on Thursday, July 12, 200...New York. Dr. Lewis,will provide an overview of th...t programs., The presentation will be webcast live...
...ER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Array Bi...ts Chief Executive Officer,Robert E. Conway, will... Conference on July 10 in New York City. The publi...ugh a webcast on the,Array BioPharma website. -0-,...owth Conference,Presenter: Robert E. Conway,...
Other Medicine Technology:ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2